CCI
ABBV icon

Columbus Circle Investors’s AbbVie ABBV Stock Holding History

Columbus Circle Investors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-664,230
Closed -$34.1M – 272
2014
Q1 		$34.1M Buy
+664,230
New +$33.6M 0.23% 117

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Columbus Circle Investors's ABBV Position: Q2 2014 in Review

Columbus Circle Investors sold out of AbbVie (ABBV) in Q2 2014, closing a stake of 664,230 shares — an estimated $34.1M sold.

Columbus Circle Investors first reported a position in ABBV in Q1 2014 and held it in 1 quarter. The position peaked at $34.1M in Q1 2014. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

  • Columbus Circle Investors reported no remaining AbbVie position as of Q2 2014 after selling out during the quarter.
  • Columbus Circle Investors sold 664,230 AbbVie shares in Q2 2014, an estimated $34.1M.
  • Columbus Circle Investors first reported a position in AbbVie in Q1 2014 and held it in 1 quarter.
  • Columbus Circle Investors's AbbVie position peaked at $34.1M in Q1 2014.
  • 1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Columbus Circle Investors's 13F filing for Q2 2014, filed 31 Jul 2014.